RU94001168A - METHOD OF TREATMENT OF PATIENTS WITH THE ONLY KIDNEY PIELONEPHRITIS - Google Patents

METHOD OF TREATMENT OF PATIENTS WITH THE ONLY KIDNEY PIELONEPHRITIS

Info

Publication number
RU94001168A
RU94001168A RU94001168/14A RU94001168A RU94001168A RU 94001168 A RU94001168 A RU 94001168A RU 94001168/14 A RU94001168/14 A RU 94001168/14A RU 94001168 A RU94001168 A RU 94001168A RU 94001168 A RU94001168 A RU 94001168A
Authority
RU
Russia
Prior art keywords
treatment
kidney
patients
single kidney
pielonephritis
Prior art date
Application number
RU94001168/14A
Other languages
Russian (ru)
Inventor
В.В. Настюков
М.П. Товбушенко
Н.П. Ненашева
О.Н. Пелихова
Р.Е. Шухнин
Original Assignee
Государственный научно-исследовательский институт курортологии в г.Пятигорске
Filing date
Publication date
Application filed by Государственный научно-исследовательский институт курортологии в г.Пятигорске filed Critical Государственный научно-исследовательский институт курортологии в г.Пятигорске
Publication of RU94001168A publication Critical patent/RU94001168A/en

Links

Claims (1)

Изобретение относится к медицине и касается лечения больных хроническим неспецифическим пиелонефритом единственной почки физическими методами. Способ позволяет устранить основные проявления заболевания за счет улучшения резервной компенсаторной возможности единственной почки, уменьшения воспалительных явлений, способствует сокращению числа дней нетрудоспособности. С этой целью ежедневно оказывают воздействие на область проекции единственной почки синусоидальными модулированными токами (СМТ). Лечение с дополнительным назначением амплипульс терапии СМТ через день способствовало более выраженному терапевтическому эффекту по сравнению с ранее известным способом лечения. Воздействие проводят с помощью аппарата "Амплипульс-4".The invention relates to medicine and relates to the treatment of patients with chronic non-specific pyelonephritis of a single kidney by physical methods. The method allows to eliminate the main manifestations of the disease by improving the reserve compensatory capacity of a single kidney, reducing inflammatory events, helps to reduce the number of days of disability. For this purpose, they daily influence the area of projection of a single kidney by sinusoidal modulated currents (SMT). Treatment with the additional prescription of the CMT therapy impulse every other day contributed to a more pronounced therapeutic effect as compared with the previously known method of treatment. The impact is carried out using the apparatus "Amplipulse-4".
RU94001168/14A 1994-01-10 METHOD OF TREATMENT OF PATIENTS WITH THE ONLY KIDNEY PIELONEPHRITIS RU94001168A (en)

Publications (1)

Publication Number Publication Date
RU94001168A true RU94001168A (en) 1995-10-27

Family

ID=

Similar Documents

Publication Publication Date Title
DK0869808T3 (en) Use of Glu-Trp dipeptides for the preparation of a drug for the treatment of various conditions involving neovascularization
ES2165910T3 (en) NASAL AND OCULAR CETAMINE ADMINISTRATION FOR THE TREATMENT OF PAIN AND FOR DETOXIFICATION.
DK1593393T3 (en) Anti-TNF antibodies and methotrexate in the concomitant treatment of autoimmune diseases
BR0206160A (en) Use of anti-TNF antibodies as medicines in the treatment of septic disorders of anemic patients.
RU96101193A (en) ANTIBODY FRAGMENTS IN THERAPY
AU1520195A (en) Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
EE03265B1 (en) Pain is relieved by opioid peptides and their use
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
DK0998287T3 (en) Use of levobupivacaine
DK0501705T3 (en) Use of tomoxetine for the treatment of diseases of the lower urinary tract
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
PT1039900E (en) THERAPEUTIC AGENTS
RU2004137823A (en) THERAPEUTIC AGAINST HYPERCALCEMIC CRISIS
IL130785A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with an autoimmune disease or chronic immune system disorder and pharmaceutical compositions containing the same
DK0781560T3 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for treatment and prevention
SE9902597D0 (en) New use
RU94001168A (en) METHOD OF TREATMENT OF PATIENTS WITH THE ONLY KIDNEY PIELONEPHRITIS
ES1022449Y (en) THERAPEUTIC APPARATUS FOR TREATMENT OF SYMPTOMS CAUSED BY DISEASES.
EE9900010A (en) Therapeutic applications of T-BAM (CD40L) technology for the treatment of smooth muscle cell related diseases
HK1015692A1 (en) Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections
HUP9903679A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
MA26796A1 (en) AMINOTETRALIN DERIVATIVE FOR THERAPY OF CARDIOVASCULAR DISEASES.
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
MX9704887A (en) Pharmaceutical compositions for the treatment of depressive disorders.
RU96114547A (en) METHOD FOR INCREASING THE ACTIVITY OF SYSTEMS OF NON-SPECIFIC BIOLOGICAL PROTECTION OF THE ORGANISM